BR112013005912A2 - métodos de tratar o aumento de próstata, de decrescer os níveis de triglicerídeos em sangue, de reduzir os níveis de glicose, de aumentar o peso pós-natal, de aumentar as taxas de sobrevivência pós-natal de prole, de aumentar a função imunológica, e de tratar distúrbio de déficit de atenção, composição de fórmula para bebê, composição nutricional, e, ingrediente alimentício - Google Patents

métodos de tratar o aumento de próstata, de decrescer os níveis de triglicerídeos em sangue, de reduzir os níveis de glicose, de aumentar o peso pós-natal, de aumentar as taxas de sobrevivência pós-natal de prole, de aumentar a função imunológica, e de tratar distúrbio de déficit de atenção, composição de fórmula para bebê, composição nutricional, e, ingrediente alimentício

Info

Publication number
BR112013005912A2
BR112013005912A2 BR112013005912A BR112013005912A BR112013005912A2 BR 112013005912 A2 BR112013005912 A2 BR 112013005912A2 BR 112013005912 A BR112013005912 A BR 112013005912A BR 112013005912 A BR112013005912 A BR 112013005912A BR 112013005912 A2 BR112013005912 A2 BR 112013005912A2
Authority
BR
Brazil
Prior art keywords
increasing
methods
increasing postnatal
attention deficit
immune function
Prior art date
Application number
BR112013005912A
Other languages
English (en)
Other versions
BR112013005912B1 (pt
Inventor
Maria Pilar Herrero
Warren E Shafer
Original Assignee
Valent Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valent Biosciences Corp filed Critical Valent Biosciences Corp
Publication of BR112013005912A2 publication Critical patent/BR112013005912A2/pt
Publication of BR112013005912B1 publication Critical patent/BR112013005912B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/105Aliphatic or alicyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/50Feeding-stuffs specially adapted for particular animals for rodents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
  • Dairy Products (AREA)

Abstract

métodos de tratar o aumento de próstata, de decrescer os níveis de triglicerídeos em sangue, de reduzir os níveis de glicose, de aumentar o peso pós-natal, de aumentar as taxas de sobrevivência pós-natal de prole, de aumentar a função imunológica, e de tratar distúrbio de déficit de atenção, composição de fórmula para bebê, composição nutricional, e, ingrediente alimentício. a invenção refere-se às composições contendo ácido abscísico, e/ou seus sais, derivados e análogos, e aos métodos de uso farmacêutico e/ou nutracêutico.
BR112013005912-5A 2010-09-17 2011-09-19 Uso de ácido abscísico, e, composição nutricional BR112013005912B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38402010P 2010-09-17 2010-09-17
US61/384,020 2010-09-17
PCT/US2011/052173 WO2012037562A2 (en) 2010-09-17 2011-09-19 Pharmaceutical and nutraceutical compositions of abscisic acid

Publications (2)

Publication Number Publication Date
BR112013005912A2 true BR112013005912A2 (pt) 2016-05-17
BR112013005912B1 BR112013005912B1 (pt) 2021-07-13

Family

ID=45818303

Family Applications (4)

Application Number Title Priority Date Filing Date
BR112013005914-1A BR112013005914B1 (pt) 2010-09-17 2011-09-19 Métodos para aumentar o ganho de peso de animais de criação ou peixes, para decrescer o tempo para comercializar animais de criação ou peixes, e, para aumentar a quantidade de carne de animais de criação ou peixes
BR112013005912-5A BR112013005912B1 (pt) 2010-09-17 2011-09-19 Uso de ácido abscísico, e, composição nutricional
BR122019010112-4A BR122019010112B1 (pt) 2010-09-17 2011-09-19 Uso de ácido abscísico (aba) para fabricação de um medicamento para aumentar a função imunológica
BR112013005915-0A BR112013005915B1 (pt) 2010-09-17 2011-09-19 Uso de ácido abscísico e método para aumentar número de proles por ninhada

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112013005914-1A BR112013005914B1 (pt) 2010-09-17 2011-09-19 Métodos para aumentar o ganho de peso de animais de criação ou peixes, para decrescer o tempo para comercializar animais de criação ou peixes, e, para aumentar a quantidade de carne de animais de criação ou peixes

Family Applications After (2)

Application Number Title Priority Date Filing Date
BR122019010112-4A BR122019010112B1 (pt) 2010-09-17 2011-09-19 Uso de ácido abscísico (aba) para fabricação de um medicamento para aumentar a função imunológica
BR112013005915-0A BR112013005915B1 (pt) 2010-09-17 2011-09-19 Uso de ácido abscísico e método para aumentar número de proles por ninhada

Country Status (10)

Country Link
US (9) US8536224B2 (pt)
EP (5) EP3228311A3 (pt)
JP (8) JP5898206B2 (pt)
CN (6) CN103179963B (pt)
BR (4) BR112013005914B1 (pt)
CA (2) CA2809641C (pt)
DK (1) DK2616059T3 (pt)
ES (2) ES2545867T3 (pt)
MX (7) MX340147B (pt)
WO (3) WO2012037563A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103179963B (zh) * 2010-09-17 2016-07-06 美商华仑生物科学公司 用于动物健康的脱落酸的组合物
CN106132207A (zh) 2014-01-10 2016-11-16 瓦伦特生物科学公司 (s)‑3’‑甲基‑脱落酸及其酯
WO2016007587A2 (en) 2014-07-08 2016-01-14 Valent Biosciences Corporation 3'-substituted-abscisic acid derivatives
ES2834574T3 (es) 2014-07-17 2021-06-17 Nutravis S R L Un nuevo tratamiento para mejorar el uso del azúcar dietético con fines energéticos
MX2023007147A (es) 2020-12-16 2023-06-27 Sumitomo Chemical Co Alimento para cerdos mezclado con acido abscisico.
US20240114926A1 (en) * 2020-12-16 2024-04-11 Sumitomo Chemical Company, Limited Livestock Feed
TW202301989A (zh) 2021-02-17 2023-01-16 日商住友化學股份有限公司 家畜用飼料
CA3203861A1 (en) 2021-02-17 2022-08-25 Hiroshi Kojo Livestock feed
US20240049752A1 (en) 2021-02-17 2024-02-15 Sumitomo Chemical Company, Limited Livestock Feed
TW202304315A (zh) 2021-04-07 2023-02-01 日商住友化學股份有限公司 家畜用飼料
US20220369630A1 (en) * 2021-05-06 2022-11-24 Stoller Enterprises, Inc. Stable S-(+)-Abscisic Acid Nonaqueous Liquid Solutions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1182508A (en) 1914-09-05 1916-05-09 Underwood Typewriter Co Automatic type-writer operator.
US1184608A (en) 1915-06-07 1916-05-23 Berger Specialty Mfg Company Inc Bottle-holder.
US3958025A (en) * 1972-10-06 1976-05-18 Livingston Virginia W C Abscisic acid tablets and process
US4209530A (en) 1978-07-28 1980-06-24 Endowment And Research Foundation At Montana State University Insect control compositions employing abscisic acid
US4434180A (en) 1978-07-28 1984-02-28 Visscher Saralee N Insect control methods with abscisic acid
US5834473A (en) * 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
EP0714305B1 (en) * 1993-08-27 2001-12-19 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
JP2001181632A (ja) * 1999-10-14 2001-07-03 Nisshin Oil Mills Ltd:The 抗酸化剤
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
US7718699B1 (en) 2005-03-04 2010-05-18 Broyles Robert H Abscissic acid and derivatives thereof for the treatment of diseases
CN100426996C (zh) * 2004-08-02 2008-10-22 阳麈苇 脱落酸抗癌保健饮料
CN1748674A (zh) * 2004-09-14 2006-03-22 中国科学院成都生物研究所 天然脱落酸用于制备肿瘤细胞“分化诱导剂”药物的新用途
JP2006232807A (ja) * 2005-01-27 2006-09-07 Toyobo Co Ltd 西洋わさび抽出物を含む抗酸化剤
CN1686174A (zh) * 2005-04-18 2005-10-26 杨奇彪 防治恶性肿瘤的抑瘤素配方
EP1714673A1 (en) * 2005-04-21 2006-10-25 Desol BV Method for lengthening the mobility period of fish
EP1714674A1 (en) * 2005-04-21 2006-10-25 Desol BV Method for improving the fertility of animals
US8389024B2 (en) 2005-06-22 2013-03-05 Gonzalo Romero M. Abscisic acid against cancer
US20060292215A1 (en) 2005-06-22 2006-12-28 Gonzalo Romero M Abscisic acid against cancer
ITTO20050708A1 (it) 2005-10-07 2007-04-08 Univ Degli Studi Genova Fluridone come agente anti-infiammatorio
US7741367B2 (en) * 2006-02-08 2010-06-22 Virginia Tech Intellectual Properties, Inc. Method of using abscisic acid to treat diseases and disorders
US8367727B2 (en) * 2006-02-08 2013-02-05 Virginia Tech Intellectual Properties, Inc. Method of using abscisic acid to treat diseases and disorders
JP2008074725A (ja) * 2006-09-19 2008-04-03 Noevir Co Ltd 保湿剤、アルギナーゼ活性促進剤、細胞賦活剤、コラーゲン産生促進剤、ヒアルロン酸産生促進剤、抗酸化剤、及び中性脂肪蓄積抑制剤
JP2009000045A (ja) * 2007-06-21 2009-01-08 Unitika Ltd 飼料配合剤
JP5268086B2 (ja) * 2007-10-02 2013-08-21 国立大学法人岩手大学 冬虫夏草の培養方法及び冬虫夏草を有効成分とする免疫賦活剤、がん細胞増殖抑制剤、抗炎症剤、又は抗酸化剤
US8320308B2 (en) 2007-11-07 2012-11-27 Stmicroelectronics, Inc. Parallel data services and spectrum sensing with cognitive channel switching in a wireless area network
US9063122B2 (en) * 2008-10-17 2015-06-23 Alfredo Gallegos Biomodulators for treatment or prevention of disease
JP5451281B2 (ja) 2009-09-16 2014-03-26 ピーエスフォー ルクスコ エスエイアールエル センスアンプ回路及びそれを備えた半導体装置
US8993624B2 (en) * 2010-05-26 2015-03-31 Virginia Tech Intellectual Properties, Inc. Method of preventing and treating inflammatory diseases and disorders with abscisic acid
CN103179963B (zh) * 2010-09-17 2016-07-06 美商华仑生物科学公司 用于动物健康的脱落酸的组合物

Also Published As

Publication number Publication date
US20130345308A1 (en) 2013-12-26
EP2616059A2 (en) 2013-07-24
JP2019031557A (ja) 2019-02-28
BR112013005914A2 (pt) 2016-05-17
EP2616060A1 (en) 2013-07-24
CN103179963A (zh) 2013-06-26
JP7217763B2 (ja) 2023-02-03
CA2809641C (en) 2019-09-10
WO2012037562A3 (en) 2012-08-02
BR112013005912B1 (pt) 2021-07-13
US20220023243A1 (en) 2022-01-27
EP2616058A4 (en) 2013-10-09
MX340983B (es) 2016-08-01
JP2019163315A (ja) 2019-09-26
CN111494353A (zh) 2020-08-07
WO2012037561A1 (en) 2012-03-22
US9591867B2 (en) 2017-03-14
BR112013005914B1 (pt) 2020-10-06
EP2616060A4 (en) 2013-10-09
BR112013005915B1 (pt) 2021-10-05
MX2013002947A (es) 2013-05-09
EP2616059B1 (en) 2017-07-05
EP2616060B1 (en) 2015-08-12
EP2616058B1 (en) 2015-08-12
US20120071557A1 (en) 2012-03-22
ES2545867T3 (es) 2015-09-16
EP3228311A3 (en) 2018-01-10
MX2013002948A (es) 2013-05-09
WO2012037563A1 (en) 2012-03-22
US8536224B2 (en) 2013-09-17
US20170143651A1 (en) 2017-05-25
CN105878224A (zh) 2016-08-24
MX340752B (es) 2016-07-22
EP3228311A2 (en) 2017-10-11
JP2023012490A (ja) 2023-01-25
CN103179964A (zh) 2013-06-26
MX340751B (es) 2016-07-22
JP2021075557A (ja) 2021-05-20
CN105640929A (zh) 2016-06-08
JP5898206B2 (ja) 2016-04-06
JP6602440B2 (ja) 2019-11-06
US20140364501A1 (en) 2014-12-11
DK2616059T3 (en) 2017-10-23
US20150250209A1 (en) 2015-09-10
US10238613B2 (en) 2019-03-26
BR112013005915A2 (pt) 2016-05-17
EP2616058A1 (en) 2013-07-24
US20120071555A1 (en) 2012-03-22
JP2013542925A (ja) 2013-11-28
USRE48854E1 (en) 2021-12-21
CN103179964B (zh) 2015-12-02
JP2016166188A (ja) 2016-09-15
US8729122B2 (en) 2014-05-20
CA3047772C (en) 2021-07-20
EP2616059A4 (en) 2014-03-26
JP2020019782A (ja) 2020-02-06
EP3598970A1 (en) 2020-01-29
CN103179963B (zh) 2016-07-06
CA2809641A1 (en) 2012-03-22
MX340147B (es) 2016-06-28
ES2545866T3 (es) 2015-09-16
WO2012037562A2 (en) 2012-03-22
CA3047772A1 (en) 2012-03-22
MX2013002949A (es) 2013-05-09
BR122019010112B1 (pt) 2021-12-21
CN103179965A (zh) 2013-06-26
JP2017222688A (ja) 2017-12-21
ES2545867T9 (es) 2017-02-17
US20120071556A1 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
BR112013005912A2 (pt) métodos de tratar o aumento de próstata, de decrescer os níveis de triglicerídeos em sangue, de reduzir os níveis de glicose, de aumentar o peso pós-natal, de aumentar as taxas de sobrevivência pós-natal de prole, de aumentar a função imunológica, e de tratar distúrbio de déficit de atenção, composição de fórmula para bebê, composição nutricional, e, ingrediente alimentício
CY1120466T1 (el) Μεθοδος βελτιωσης του φυσιολογικου θαμβους
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
BR112013028908A2 (pt) anticorpos c-kit e usos dos mesmos
PH12016500764A1 (en) Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
TN2015000185A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
PH12016500846A1 (en) Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
UA111386C2 (uk) Піридопіразини, які мають протиракову активність через інгібування fgfr-кіназ
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
CO7151486A2 (es) Sal de tipo camsilato
BR112013000497A2 (pt) arranjo de fómulas nutricionais projetadas de acordo com a idade com teor ótimo de gordura
MX342947B (es) Tratamiento de diabetes tipo 2.
EA201592003A1 (ru) Микропищевые добавки для иммунитета
BR112015021649A2 (pt) fórmula para bebês com um baixo teor de ácidos graxos de cadeia média em proporções específicas, e o uso da mesma para promover e/ou assegurar um crescimento equilibrado de bebês
BR112017004294A2 (pt) composição nutricional com baixo teor de ácidos graxos de cadeia média em proporções específicas e seus usos
MY173927A (en) Formula fortifier
NZ626540A (en) Glutamine enriched nutritional composition for preterm infants
BR112013021376A2 (pt) composição para aumentar a estabilidade da articulação e/ou postural
MX2017007951A (es) Nutricion infantil con proteina hidrolizada y acido palmitico.
PH12014501569A1 (en) Glutamine enriched nutritional composition for preterm infants
BR112014019486A8 (pt) Uso de um oligossacarídeo não digerível como um suplemento materno
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
BR112015023316A2 (pt) fórmula para bebês de baixa caloria contendo ácido beta-hidroxi-beta-metilbutírico para promover a síntese de proteína e a acreção de massa corporal magra em bebês nascidos a termo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/09/2011, OBSERVADAS AS CONDICOES LEGAIS.